Study ID: FSS-AS-201
Study Title
- Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Teva Identifier
- FSS-AS-201
ClinicalTrials.gov Identifier
- NCT01772368
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Fp MDPI | Drug: FS MDPI | Drug: Advair Diskus | Drug: Albuterol
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- 01/01/2013 - 06/01/2013
Phase
- Phase 2
Study Type
Interventional